Toggle navigation
Home
Search
Services
Blog
Contact
About
Covalent protein-ligand binding affinities with VM2
Webb, Simon
Verachem, LLC, Germantown, MD, United States
Search 14 grants from Simon Webb
Search grants from Verachem, LLC
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Hypoxia-induced reprogramming to RPE stem cells
ROS in Intermittent Hypoxia-Mediated Neuronal Cell Death
Gsh Transferase Pi Polymorphism and Drug Resistance
Mechanisms of Post-Injury Organ Failure
Tachykinins and Tachykinin Receptors
Recently added grants:
The Impact of Tobacco Control Policies on Health Equity in the United States
Safer Approaches to CRC Chemoprevention
Exploring the shared genetic architecture of white blood cell variation and childhood acute lymphoblastic leukemia
DNA damage signaling to dormant origins of replication
Metabolic adaptation in lymphoid malignancies
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
4R44GM137634-02
Application #
10137371
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Lyster, Peter
Project Start
2020-06-01
Project End
2022-11-30
Budget Start
2020-12-03
Budget End
2021-11-30
Support Year
2
Fiscal Year
2021
Total Cost
Indirect Cost
Institution
Name
Verachem, LLC
Department
Type
DUNS #
059476114
City
Germantown
State
MD
Country
United States
Zip Code
20875
Related projects
NIH 2021
R44 GM
Covalent protein-ligand binding affinities with VM2
Webb, Simon / Verachem, LLC
NIH 2020
R44 GM
Covalent protein-ligand binding affinities with VM2
Webb, Simon / Verachem, LLC
Comments
Be the first to comment on this grant